These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12032341)

  • 21. A comparison of Shiga-toxin negative Escherichia coli O157 aflagellate and intimin deficient mutants in porcine in vitro and in vivo models of infection.
    Best A; La Ragione RM; Clifford D; Cooley WA; Sayers AR; Woodward MJ
    Vet Microbiol; 2006 Mar; 113(1-2):63-72. PubMed ID: 16337755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
    Sheoran AS; Dmitriev IP; Kashentseva EA; Cohen O; Mukherjee J; Debatis M; Shearer J; Tremblay JM; Beamer G; Curiel DT; Shoemaker CB; Tzipori S
    Infect Immun; 2015 Jan; 83(1):286-91. PubMed ID: 25368111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
    Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
    Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variants of eae and stx genes of atypical enteropathogenic Escherichia coli and non-O157 Shiga toxin-producing Escherichia coli from calves.
    Wani SA; Hussain I; Nabi A; Fayaz I; Nishikawa Y
    Lett Appl Microbiol; 2007 Dec; 45(6):610-5. PubMed ID: 17916128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First isolation of Shiga toxin 1d producing Escherichia coli variant strains in shellfish from coastal areas in France.
    Gourmelon M; Montet MP; Lozach S; Le Mennec C; Pommepuy M; Beutin L; Vernozy-Rozand C
    J Appl Microbiol; 2006; 100(1):85-97. PubMed ID: 16405688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral administration of formaldehyde-killed recombinant bacteria expressing a mimic of the Shiga toxin receptor protects mice from fatal challenge with Shiga-toxigenic Escherichia coli.
    Paton JC; Rogers TJ; Morona R; Paton AW
    Infect Immun; 2001 Mar; 69(3):1389-93. PubMed ID: 11179303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7.
    Calderon Toledo C; Rogers TJ; Svensson M; Tati R; Fischer H; Svanborg C; Karpman D
    Am J Pathol; 2008 Nov; 173(5):1428-39. PubMed ID: 18832584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a Shiga-toxin type I variant containing an IS1203-like element, from Shiga-toxin producing Escherichia coli O157:H7.
    Suzuki M; Kondo F; Ito Y; Matsumoto M; Hata M; Oka H; Takahashi M; Sakae K
    FEMS Microbiol Lett; 2004 May; 234(1):63-7. PubMed ID: 15109720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multiple protocol to improve diagnosis and isolation of Shiga toxin-producing Escherichia coli from human stool specimens.
    Shelton DR; Karns JS; Park CH
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):7-10. PubMed ID: 18550318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.
    Bielaszewska M; Friedrich AW; Aldick T; Schürk-Bulgrin R; Karch H
    Clin Infect Dis; 2006 Nov; 43(9):1160-7. PubMed ID: 17029135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.
    Brooks JT; Sowers EG; Wells JG; Greene KD; Griffin PM; Hoekstra RM; Strockbine NA
    J Infect Dis; 2005 Oct; 192(8):1422-9. PubMed ID: 16170761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution.
    Bielaszewska M; Middendorf B; Köck R; Friedrich AW; Fruth A; Karch H; Schmidt MA; Mellmann A
    Clin Infect Dis; 2008 Jul; 47(2):208-17. PubMed ID: 18564929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.
    Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L
    Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of postinfection treatment with anti-Shiga toxin (Stx) 2 humanized monoclonal antibody TMA-15 in mice lethally challenged with Stx-producing Escherichia coli.
    Yamagami S; Motoki M; Kimura T; Izumi H; Takeda T; Katsuura Y; Matsumoto Y
    J Infect Dis; 2001 Sep; 184(6):738-42. PubMed ID: 11517435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of pathogenic Escherichia coli isolated from humans in Austria: phenotypes, toxin gene types and epidemiology.
    Wagner M; Allerberger F; Manafi M; Lindner G; Friedrich AW; Sonntag AK; Foissy H
    J Vet Med B Infect Dis Vet Public Health; 2004 Aug; 51(6):288-92. PubMed ID: 15458492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo.
    Miyamoto Y; Iimura M; Kaper JB; Torres AG; Kagnoff MF
    Cell Microbiol; 2006 May; 8(5):869-79. PubMed ID: 16611235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins.
    Liu J; Sun Y; Feng S; Zhu L; Guo X; Qi C
    Vaccine; 2009 Oct; 27(43):5929-35. PubMed ID: 19682616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory-confirmed non-O157 Shiga toxin-producing Escherichia coli--Connecticut, 2000-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jan; 56(2):29-31. PubMed ID: 17230143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.
    Johnson KE; Thorpe CM; Sears CL
    Clin Infect Dis; 2006 Dec; 43(12):1587-95. PubMed ID: 17109294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shiga toxin-producing Escherichia coli in healthy young beef steers from Argentina: prevalence and virulence properties.
    Meichtri L; Miliwebsky E; Gioffré A; Chinen I; Baschkier A; Chillemi G; Guth BE; Masana MO; Cataldi A; Rodríguez HR; Rivas M
    Int J Food Microbiol; 2004 Nov; 96(2):189-98. PubMed ID: 15364473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.